Aliment Pharmacol Ther

1. RAYMENANTS K, Tack J
   Editorial: refractory reflux sensitivity-A place for baclofen? Authors' reply.
   Aliment Pharmacol Ther. 2022;56:725-726.
   

   >> Share

   
   
2. KATZ PO
   Editorial: refractory reflux sensitivity - a place for baclofen?
   Aliment Pharmacol Ther. 2022;56:723-724.
   

   >> Share

   
   
3. ANG D
   Letter: a promising Helicobacter pylori regimen-vonoprazan-based therapy. Author's reply.
   Aliment Pharmacol Ther. 2022;56:754-755.
   

   >> Share

   
   
4. HU Y, Lu NH
   Letter: a promising Helicobacter pylori regimen - vonoprazan-based therapy.
   Aliment Pharmacol Ther. 2022;56:752-753.
   

   >> Share

   
   

   
   BMC Gastroenterol

5. WANG R, Wang Q
   Comparison of risk scoring systems for upper gastrointestinal bleeding in patients after renal transplantation: a retrospective observational study in Hunan, China.
   BMC Gastroenterol. 2022;22:353.
   

   >> Share

   
   

   
   Helicobacter

6. MUNIR M, LeMaitre B, Lobo Z, Psevdos G, et al
   A 15-year review of Helicobacter pylori screening and treatment among United States Veterans.
   Helicobacter. 2022 Jul 28:e12919. doi: 10.1111/hel.12919.
   

   >> Share

   
   
7. MOMMERSTEEG MC, Yu BT, van den Bosch TPP, von der Thusen JH, et al
   Constitutive programmed death ligand 1 expression protects gastric G-cells from Helicobacter pylori-induced inflammation.
   Helicobacter. 2022 Jul 28:e12917. doi: 10.1111/hel.12917.
   

   >> Share

   
   
8. GAO W, Teng G, Wang C, Xu Y, et al
   Eradication rate and safety of a "simplified rescue therapy": 14-day vonoprazan and amoxicillin dual regimen as rescue therapy on treatment of Helicobacter pylori infection previously failed in eradication: A real-world, retrospective clinical study i
   Helicobacter. 2022 Jul 25:e12918. doi: 10.1111/hel.12918.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share